Show simple item record

Adipose-Derived Regenerative Cell Transplantation for the Treatment of Hand Dysfunction in Systemic Sclerosis: A Randomized Clinical Trial

dc.contributor.authorKhanna, Dinesh
dc.contributor.authorCaldron, Paul
dc.contributor.authorMartin, Richard W.
dc.contributor.authorKafaja, Suzanne
dc.contributor.authorSpiera, Robert
dc.contributor.authorShahouri, Shadi
dc.contributor.authorShah, Ankoor
dc.contributor.authorHsu, Vivien
dc.contributor.authorErvin, John
dc.contributor.authorSimms, Robert
dc.contributor.authorDomsic, Robyn T.
dc.contributor.authorSteen, Virginia
dc.contributor.authorHummers, Laura K.
dc.contributor.authorDerk, Chris
dc.contributor.authorMayes, Maureen
dc.contributor.authorChatterjee, Soumya
dc.contributor.authorVarga, John
dc.contributor.authorKesten, Steven
dc.contributor.authorFraser, John K.
dc.contributor.authorFurst, Daniel E.
dc.date.accessioned2022-08-02T18:59:27Z
dc.date.available2023-09-02 14:59:25en
dc.date.available2022-08-02T18:59:27Z
dc.date.issued2022-08
dc.identifier.citationKhanna, Dinesh; Caldron, Paul; Martin, Richard W.; Kafaja, Suzanne; Spiera, Robert; Shahouri, Shadi; Shah, Ankoor; Hsu, Vivien; Ervin, John; Simms, Robert; Domsic, Robyn T.; Steen, Virginia; Hummers, Laura K.; Derk, Chris; Mayes, Maureen; Chatterjee, Soumya; Varga, John; Kesten, Steven; Fraser, John K.; Furst, Daniel E. (2022). "Adipose-Derived Regenerative Cell Transplantation for the Treatment of Hand Dysfunction in Systemic Sclerosis: A Randomized Clinical Trial." Arthritis & Rheumatology 74(8): 1399-1408.
dc.identifier.issn2326-5191
dc.identifier.issn2326-5205
dc.identifier.urihttps://hdl.handle.net/2027.42/173150
dc.publisherWiley Periodicals, Inc.
dc.titleAdipose-Derived Regenerative Cell Transplantation for the Treatment of Hand Dysfunction in Systemic Sclerosis: A Randomized Clinical Trial
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelRheumatology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/173150/1/art42133_am.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/173150/2/art42133-sup-0001-Disclosureform.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/173150/3/art42133-sup-0004-FigureS2.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/173150/4/art42133.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/173150/5/art42133-sup-0003-FigureS1.pdf
dc.identifier.doi10.1002/art.42133
dc.identifier.sourceArthritis & Rheumatology
dc.identifier.citedreferenceRevicki D, Hays RD, Cella D, Sloan J. Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epidemiol 2008; 61: 102 – 9.
dc.identifier.citedreferenceDenton CP, Khanna D. Systemic sclerosis. Lancet 2017; 390: 1685 – 99.
dc.identifier.citedreferenceSingh MK, Clements PJ, Furst DE, Maranian P, Khanna D. Work productivity in scleroderma: analysis from the University of California, Los Angeles scleroderma quality of life study. Arthritis Care Res (Hoboken) 2012; 64: 176 – 83.
dc.identifier.citedreferenceMaddali-Bongi S, Del Rosso A, Mikhaylova S, Francini B, Branchi A, Baccini M, et al. Impact of hand and face disabilities on global disability and quality of life in systemic sclerosis patients. Clin Exp Rheumatol 2014; 32: S15 – 20.
dc.identifier.citedreferenceSerratrice N, Bruzzese L, Magalon J, Veran J, Giraudo L, Aboudou H, et al. New fat-derived products for treating skin-induced lesions of scleroderma in nude mice. Stem Cell Res Ther 2014; 5: 138.
dc.identifier.citedreferenceKesten S, Fraser JK. Autologous adipose derived regenerative cells: a platform for therapeutic applications. Surg Technol Int 2016; 29: 38 – 44.
dc.identifier.citedreferenceFraser JK, Hicok KC, Shanahan R, Zhu M, Miller S, Arm DM. The Celution system: automated processing of adipose-derived regenerative cells in a functionally closed system. Adv Wound Care (New Rochelle) 2014; 3: 38 – 45.
dc.identifier.citedreferenceGuillaume-Jugnot P, Daumas A, Magalon J, Jouve E, Nguyen PS, Truillet R, et al. Autologous adipose-derived stromal vascular fraction in patients with systemic sclerosis: 12-month follow-up. Rheumatology (Oxford) 2016; 55: 301 – 6.
dc.identifier.citedreferenceGranel B, Daumas A, Jouve E, Harle JR, Nguyen PS, Chabannon C, et al. Safety, tolerability and potential efficacy of injection of autologous adipose-derived stromal vascular fraction in the fingers of patients with systemic sclerosis: an open-label phase I trial. Ann Rheum Dis 2015; 74: 2175 – 82.
dc.identifier.citedreferenceDaumas A, Magalon J, Jouve E, Truillet R, Casanova D, Giraudo L, et al. Long-term follow-up after autologous adipose-derived stromal vascular fraction injection into fingers in systemic sclerosis patients. Curr Res Transl Med 2017; 65: 40 – 3.
dc.identifier.citedreferenceVan den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2013; 65: 2737 – 47.
dc.identifier.citedreferenceLeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, et al. Scleroderma (systemic sclerosis): classification, subsets, and pathogenesis. J Rheumatol 1988; 15: 202 – 5.
dc.identifier.citedreferenceRannou F, Poiraudeau S, Berezne A, Baubet T, Le-Guern V, Cabane J, et al. Assessing disability and quality of life in systemic sclerosis: construct validities of the Cochin Hand Function Scale, health assessment questionnaire (HAQ), systemic sclerosis HAQ, and medical outcomes study 36-item short form health survey. Arthritis Rheum 2007; 57: 94 – 102.
dc.identifier.citedreferenceBrower LM, Poole JL. Reliability and validity of the Duruoz Hand Index in persons with systemic sclerosis (scleroderma). Arthritis Rheum 2004; 51: 805 – 9.
dc.identifier.citedreferenceSteen VD, Medsger TA Jr. The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time. Arthritis Rheum 1997; 40: 1984 – 91.
dc.identifier.citedreferenceFries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980; 23: 137 – 45.
dc.identifier.citedreferenceKhanna PP, Maranian P, Gregory J, Khanna D. The minimally important difference and patient acceptable symptom state for the Raynaud’s condition score in patients with Raynaud’s phenomenon in a large randomised controlled clinical trial. Ann Rheum Dis 2010; 69: 588 – 91.
dc.identifier.citedreferenceEuroQol G. EuroQol—a new facility for the measurement of health-related quality of life. Health Policy 1990; 16: 199 – 208.
dc.identifier.citedreferenceClements PJ, Lachenbruch PA, Ng SC, Simmons M, Sterz M, Furst DE. Skin score: a semiquantitative measure of cutaneous involvement that improves prediction of prognosis in systemic sclerosis. Arthritis Rheum 1990; 33: 1256 – 63.
dc.identifier.citedreferenceMaihafer GC, Llewellyn MA, Pillar WJ Jr, Scott KL, Marino DM, Bond RM. A comparison of the figure-of-eight method and water volumetry in measurement of hand and wrist size. J Hand Ther 2003; 16: 305 – 10.
dc.identifier.citedreferenceWright A, Hannon J, Hegedus EJ, Kavchak AE. Clinimetrics corner: a closer look at the minimal clinically important difference (MCID). J Man Manip Ther 2012; 20: 160 – 6.
dc.identifier.citedreferenceKhanna D, Furst DE, Hays RD, Park GS, Wong WK, Seibold JR, et al. Minimally important difference in diffuse systemic sclerosis: results from the D-penicillamine study. Ann Rheum Dis 2006; 65: 1325 – 9.
dc.identifier.citedreferenceAllanore Y, Simms R, Distler O, Trojanowska M, Pope J, Denton CP, et al. Systemic sclerosis. Nat Rev Dis Primers 2015; 1: 15002.
dc.identifier.citedreferenceCutolo M, Sulli A, Smith V. Assessing microvascular changes in systemic sclerosis diagnosis and management [review]. Nat Rev Rheumatol 2010; 6: 578 – 87.
dc.identifier.citedreferenceVarga J, Trojanowska M, Kuwana M. Pathogenesis of systemic sclerosis: recent insights of molecular and cellular mechanisms and therapeutic opportunities. J Scleroderma Relat 2017; 2: 137 – 52.
dc.identifier.citedreferenceFleming JN, Nash RA, McLeod DO, Fiorentino DF, Shulman HM, Connolly MK, et al. Capillary regeneration in scleroderma: stem cell therapy reverses phenotype? PLoS One 2008; 3: e1452.
dc.identifier.citedreferencePremaratne GU, Ma LP, Fujita M, Lin X, Bollano E, Fu M. Stromal vascular fraction transplantation as an alternative therapy for ischemic heart failure: anti-inflammatory role. J Cardiothorac Surg 2011; 6: 43.
dc.identifier.citedreferenceHarada Y, Yamamoto Y, Tsujimoto S, Matsugami H, Yoshida A, Hisatome I. Transplantation of freshly isolated adipose tissue-derived regenerative cells enhances angiogenesis in a murine model of hind limb ischemia. Biomed Res 2013; 34: 23 – 9.
dc.identifier.citedreferenceFoubert P, Doyle-Eisele M, Gonzalez A, Berard F, Weber W, Zafra D, et al. Development of a combined radiation and full thickness burn injury minipig model to study the effects of uncultured adipose-derived regenerative cell therapy in wound healing. Int J Radiat Biol 2017; 93: 340 – 50.
dc.identifier.citedreferenceFoubert P, Barillas S, Gonzalez AD, Alfonso Z, Zhao S, Hakim I, et al. Uncultured adipose-derived regenerative cells (ADRCs) seeded in collagen scaffold improves dermal regeneration, enhancing early vascularization and structural organization following thermal burns. Burns 2015; 41: 1504 – 16.
dc.identifier.citedreferenceBowles AC, Wise RM, Gerstein BY, Thomas RC, Ogelman R, Manayan RC, et al. Adipose stromal vascular fraction attenuates TH1 cell-mediated pathology in a model of multiple sclerosis. J Neuroinflammation 2018; 15: 77.
dc.identifier.citedreferenceYoshimura K, Shigeura T, Matsumoto D, Sato T, Takaki Y, Aiba-Kojima E, et al. Characterization of freshly isolated and cultured cells derived from the fatty and fluid portions of liposuction aspirates. J Cell Physiol 2006; 208: 64 – 76.
dc.identifier.citedreferenceBourin P, Bunnell BA, Casteilla L, Dominici M, Katz AJ, March KL, et al. Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT). Cytotherapy 2013; 15: 641 – 8.
dc.identifier.citedreferencePignatti M, Spinella A, Cocchiara E, Boscaini G, Lusetti IL, Citriniti G, et al. Autologous fat grafting for the oral and digital complications of systemic sclerosis: results of a prospective study. Aesthetic Plast Surg 2020; 44: 1820 – 32.
dc.identifier.citedreferenceYoung A, Namas R, Dodge C, Khanna D. Hand impairment in systemic sclerosis: various manifestations and currently available treatment. Curr Treatm Opt Rheumatol 2016; 2: 252 – 69.
dc.working.doiNOen
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.